These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Recent advances in the knowledge of sideroblastic anemia]. Fujiwara T. Rinsho Ketsueki; 2022; 63(6):600-607. PubMed ID: 35831194 [Abstract] [Full Text] [Related]
5. [Ring sideroblasts and iron metabolism]. Fujiwara T. Rinsho Ketsueki; 2020; 61(7):770-778. PubMed ID: 32759564 [Abstract] [Full Text] [Related]
6. [Biology of sideroblastic anemia]. Harigae H. Rinsho Ketsueki; 2017; 58(4):347-352. PubMed ID: 28484165 [Abstract] [Full Text] [Related]
7. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine. Kucerova J, Horvathova M, Mojzikova R, Belohlavkova P, Cermak J, Divoky V. Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495 [Abstract] [Full Text] [Related]
9. Pathophysiology and genetic mutations in congenital sideroblastic anemia. Fujiwara T, Harigae H. Pediatr Int; 2013 Dec; 55(6):675-9. PubMed ID: 24003969 [Abstract] [Full Text] [Related]
10. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias. Peoc'h K, Nicolas G, Schmitt C, Mirmiran A, Daher R, Lefebvre T, Gouya L, Karim Z, Puy H. Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140 [Abstract] [Full Text] [Related]
11. Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia. Kaneko K, Furuyama K, Fujiwara T, Kobayashi R, Ishida H, Harigae H, Shibahara S. Haematologica; 2014 Feb; 99(2):252-61. PubMed ID: 23935018 [Abstract] [Full Text] [Related]
12. Hereditary sideroblastic anemia: pathophysiology and gene mutations. Harigae H, Furuyama K. Int J Hematol; 2010 Oct; 92(3):425-31. PubMed ID: 20848343 [Abstract] [Full Text] [Related]
15. Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast Formation. Saito K, Fujiwara T, Hatta S, Morita M, Ono K, Suzuki C, Fukuhara N, Onishi Y, Nakamura Y, Kawamata S, Shimizu R, Yamamoto M, Harigae H. Mol Cell Biol; 2019 Apr 01; 39(7):. PubMed ID: 30670569 [Abstract] [Full Text] [Related]
16. Mitochondrial iron metabolism and sideroblastic anemia. Sheftel AD, Richardson DR, Prchal J, Ponka P. Acta Haematol; 2009 Apr 01; 122(2-3):120-33. PubMed ID: 19907149 [Abstract] [Full Text] [Related]
17. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts. Cotter PD, May A, Fitzsimons EJ, Houston T, Woodcock BE, al-Sabah AI, Wong L, Bishop DF. J Clin Invest; 1995 Oct 01; 96(4):2090-6. PubMed ID: 7560104 [Abstract] [Full Text] [Related]
19. The molecular basis of the sideroblastic anemias. Fitzsimons EJ, May A. Curr Opin Hematol; 1996 Mar 01; 3(2):167-72. PubMed ID: 9372069 [Abstract] [Full Text] [Related]